BioSpace News Archive

Deals

Magenta Therapeutics Launches Proposed Initial Public Offering

Magenta Therapeutics is a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients

June 8, 2018
·
4 min read
Pharm Country

PAVmed to Receive $10.4 Million in Gross Proceeds from Oversubscribed Rights Offering

Equity subscription rights offering expired at 5:00 p.m. Eastern Time on Thursday, June 7, 2018 and, as such, the rights are no longer exercisable

June 8, 2018
·
6 min read
Biotech Bay

Daly City Mayor Juslyn Manalo Proclaims June 4 to June 8, 2018 Wound Care Awareness Week

The proclamation expresses the city’s support to increase awareness and education about chronic wounds.

June 8, 2018
·
2 min read
Canadian science prodigy winner of prestigious international competition

Sajeev Kohli, a Grade 11 student from Waterloo, Ontario, receives top honours in the Global Healthcare Challenge

June 8, 2018
·
3 min read
BioMidwest

Exact Sciences Announces Upsizing and Pricing of 1.0% Convertible Senior Notes Due 2025

The initial public offering price for the Notes will be 106.5% of face value plus accrued interest from January 17, 2018.

June 8, 2018
·
5 min read
Biotech Beach

Kush Bottles, Inc. Prices $36,000,000 Registered Direct Offering

KUSH BOTTLES, INC. is a leading provider of packaging, supplies, vaporizers, hydrocarbon gases, solvents, accessories and branding solutions for the regulated cannabis industry

June 8, 2018
·
4 min read
Business

Karma Automotive To Support “In goop Health” Wellness Summit As The Official Automotive Partner

Karma Will Have a Vehicle Installation at the In goop Health Retail Hall

June 8, 2018
·
1 min read
BioMidwest

Navitus Health Solutions Shares Early Results From Its Pharmacogenomics Pilot

Navitus is continually looking for ways to reduce costs

June 8, 2018
·
3 min read
Business

Lee Health Pioneers Blood Culture Collection System, Significantly Improving Patient Safety Around Sepsis

New technology lowers healthcare costs and significantly reduces unnecessary antibiotic use

June 8, 2018
·
4 min read
Pharm Country

New Late-Breaking Data on the Use of Type 2 Diabetes Treatment INVOKANA® (canagliflozin) in the Real World Will Be Presented at the American Diabetes Association’s 78th Annual Scientific Sessions

Featured Data Includes Findings From OBSERVE-4D - the Largest Real-World Study to Evaluate the Risk of Lower Extremity Amputation and Hospitalization for Heart Failure

June 8, 2018
·
18 min read